Mako Surgical Corp. - Securities Registration (section 12(b)) (8-A12B)
15 2월 2008 - 1:36AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
MAKO Surgical Corp.
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
Delaware
(State of Incorporation or Organization)
|
|
20-1901148
(I.R.S. Employer Identification No.)
|
|
|
|
2555 Davie Road
Ft. Lauderdale, FL
(Address of Principal Executive Offices)
|
|
33317
(Zip Code)
|
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
to be so registered
|
|
Name of each exchange on which
each class is to be registered
|
|
|
|
Common Stock, $0.001 par value per share
|
|
The NASDAQ Stock Market LLC
|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the
Exchange Act and is effective pursuant to General Instruction A.(c), please check the following
box.
x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the
Exchange Act and is effective pursuant to General Instruction A.(d), please check the following
box.
o
Securities Act registration statement file number to which this form relates:
333-146162
Securities to be registered pursuant to Section 12(g) of the Act:
None.
Item 1. Description of Registrants Securities to be Registered.
The description of the common stock, par value $0.001 per share (the Common Stock), of MAKO
Surgical Corp. (the Registrant) included under the caption Description of Capital Stock in the
prospectus forming a part of the Registrants registration statement on Form S-1, which was
initially filed with the Securities and Exchange Commission on September 19, 2007 (File No.
333-146162), as amended (including any subsequent amendments, the Registration Statement), is
incorporated by reference into this registration statement. The description of the Common Stock
included in any form of prospectus subsequently filed by the Registrant pursuant to Rule 424(b)
under the Securities Act of 1933, as amended, relating to the Registration Statement, shall be
deemed to be incorporated by reference into this registration statement.
Item 2. Exhibits.
Pursuant to the instructions as to exhibits with respect to Form 8-A, no exhibits are required
to be filed herewith, because no securities of the Registrant are registered on The NASDAQ Stock
Market LLC and no securities are being registered hereby pursuant to Section 12(g) of the Exchange
Act.
2
Signature
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the
Registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
|
|
|
|
|
Date: February 14, 2008
|
MAKO Surgical Corp.
|
|
|
By:
|
/s/ Maurice R. Ferré
|
|
|
|
Maurice R. Ferré
|
|
|
|
President and Chief Executive Officer
|
|
|
3
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Mako Surgical Corp. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Mako Surgical Corp. News Articles